相关实验视频

Updated: May 5, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

ctDNA:在手术切除的肝细胞癌中个性化风险分层的门户

David J Pinato^1,2, Pasquale Lombardi^1,3, Antonio D'Alessio¹

¹Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, London, United Kingdom.

Clinical cancer research : an official journal of the American Association for Cancer Research

|January 10, 2025

概括

肝细胞癌的术后复发风险很高 (>70%). 循环瘤DNA (ctDNA) 显示了手术后个性化风险分层的前景,因为目前的辅助免疫疗法没有提供生存益处.

科学领域:

肝胆道手术是肝胆道的手术.
癌症复发癌症复发
分子诊断学分子诊断学

背景情况:

肝细胞癌 (HCC) 的手术切除具有高风险的术后复发 (>70%).
HCC复发是多因素的,涉及瘤复发或新的癌症发展.
辅助免疫治疗没有改善切除后的生存结果.

研究的目的:

探索循环瘤DNA (ctDNA) 在切除后HCC患者风险分层的实用性.
为了确定预测肝细胞癌复发的潜在生物标志物.

主要方法:

对接受为HCC进行手术切除的患者的ctDNA分析.
ctDNA水平与术后复发模式的相关性.

主要成果:

ctDNA分析可以增强对HCC复发的个性化风险评估.
对于ctDNA来说,它有可能指导高风险患者的未来治疗策略.

结论:

循环瘤DNA (ctDNA) 在肝细胞癌切除后具有改善风险分层的潜力.
需要进一步的研究来将ctDNA纳入临床实践,以管理HCC复发.

更多相关视频

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.